Diabetes Tools' TriabetesClinic Nominated for 2016 Global Mobile Awards

Diabetes ToolsDiabetes Tools has been nominated for Best Mobile Innovation for Health in the GSMA's 2016 Global Mobile Awards for its TriabetesClinic online decision support service that puts medical apps at the heart of diabetes treatment for insulin-dependent children, both in hospital and remotely at home.

"TriabetesClinic for Children combines mobile apps for patient self-care and on-ward mobility with online tools to simplify and digitally rearrange the care around each child with diabetes," said Diabetes Tools' Chief Executive Officer Anders Weilandt. "To be chosen by the Glomo Awards judging committee shows that the digital health sector is gaining ground. However, digital health still has a long way to go. This nomination energizes our team's already considerable persistence and dedication to go the distance."

"Congratulations to all of the nominees for the 2016 Glomo Awards," said Michael O’Hara, Chief Marketing Officer, GSMA. "With more than 930 entries this year - a new record - the competition is greater than ever, reflecting the tremendous diversity and pace of innovation across the mobile world. We are particularly excited to be celebrating the 21st year of the awards with a dynamic new format that will recognise and honour achievement throughout Mobile World Congress."

The Glomo Awards highlight achievements and innovations across the mobile industry and include more than 40 awards in eight categories. The 2016 winners will be announced during Mobile World Congress, the world's largest mobile industry exhibition and conference, in Barcelona, Spain (22 - 25 February). For more information, visit http://www.globalmobileawards.com/nominees2016/.

Triabetes and TriabetesClinic are registered trademarks of Diabetes Tools Sweden AB.

About Diabetes Tools
Diabetes Tools is a Swedish medical technology company that simplifies daily life for everyone involved in diabetes care. The TriabetesClinic software service securely combines apps (for smartphones and tablets), online accounts and web interfaces to change diabetes healthcare for the better.

Diabetes Tools was named "MedTech Company of the Year 2014" by the Swedish Medtech Association. The company holds an ISO 13485 certificate, a compliance standard for creating medical devices and related services, and sells CE-marked medical software products in the European Union. Diabetes Tools is privately held and located in Stockholm, Sweden.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...